News
Harnessing the Potential of Gastric Balloons: A New Era in Bariatric Medicine
Table of Contents
Introduction
Obesity, recognised as a chronic and multifactorial disease by the World Health Organization, has reached epidemic proportions globally, with nearly 13% of the world’s adult population suffering from this condition as of 2016 [1]. This growing crisis necessitates innovative solutions, and bariatric medicine has risen to this challenge, employing a range of treatment strategies to reduce and maintain body weight.
One such strategy, gaining increased acceptance and recognition, is using gastric balloons, an endoscopic bariatric therapy (EBT) designed to induce weight loss by limiting gastric capacity, thereby reducing food intake [2]. Gastric balloons, filled with saline or air, are inserted into the stomach endoscopically and cause a feeling of satiety or fullness [3]. This minimally invasive procedure offers a viable solution for those with obesity who are unable or unwilling to undergo more invasive bariatric surgeries [4].
As the understanding of obesity and related metabolic disorders deepens, the role of gastric balloons is being redefined. They serve as a weight loss tool and are part of comprehensive programs that include diet, exercise, and behaviour modifications [5]. The advent of gastric balloons signals a new era in bariatric medicine, presenting an exciting opportunity to redefine obesity management.
This article will explore gastric balloons’ evolution, effectiveness, and future potential in bariatric medicine, featuring clinical evidence, case studies, and potential advancements. The objective is to shed light on the role of this innovative tool and its potential to reshape the landscape of bariatric interventions.
Understanding the Gastric Balloon Procedure
What are Gastric Balloons, and How Do They Work?
Gastric balloons, or intragastric balloons (IGB), are soft silicone devices inserted into the stomach to aid weight loss [6]. They work by partially filling the stomach, limiting the amount of food it can hold and inducing an early feeling of fullness [7]. The patient feels satiated with a smaller quantity of food, which facilitates a reduction in overall calorie intake [8].
The Procedure for Placing a Gastric Balloon
The procedure to place a gastric balloon is typically conducted on an outpatient basis and involves several stages. The patient is first given a mild sedative [9]. A thin tube, or endoscope, carrying the deflated balloon is inserted through the mouth and into the stomach. The doctor uses the endoscope to check the stomach for any abnormalities. Once confirmed that it’s safe, the balloon is filled with saline or air [10].
Post-procedure, the patient is monitored briefly before being discharged home. Patients can generally return to their normal activities within a day or two. The balloon is typically left in place for around six months, after which it is deflated and removed using a similar endoscopic procedure [11].
Candidates for Gastric Balloon Procedure
Gastric balloons are considered a non-surgical weight loss solution suitable for various candidates. They are recommended for individuals with a Body Mass Index (BMI) of 30 to 40 who are not eligible or willing to undergo surgical bariatric procedures [12].
They can also be used as a “bridge” therapy for high-risk patients who need to lose weight before they can safely undergo other surgeries [13]. Notably, the procedure’s suitability depends on the patient’s overall health status, as individuals with certain stomach or oesophagal disorders or previous stomach surgery may not be appropriate candidates [14].
Gastric balloons, as a part of a comprehensive weight management program, are increasingly recognised as a significant asset in the battle against obesity. By understanding the procedure and the potential candidates, we can maximise their potential and redefine obesity management.
The Evolution of Gastric Balloons in Bariatric Medicine
The History and Evolution of Gastric Balloons
Gastric balloons have been used for several decades, with the first device introduced in the early 1980s [15]. Initially, they faced criticism due to the high rate of complications and suboptimal weight loss results. However, with improvements in design and the introduction of new materials, the safety and efficacy of the devices improved considerably [16].
Over time, manufacturers introduced modifications to the initial design, such as adjustable volumes and different fill materials, like saline and air. Advanced imaging techniques during placement and removal also increased safety and effectiveness [17].
Advancements in Gastric Balloon Technology
The last decade has seen a significant leap in gastric balloon technology. Modern balloons like dual-balloon and swallowable balloon systems have improved patient tolerance and weight loss outcomes [18]. For example, dual-balloon systems aim to enhance tolerance by conforming to the shape of the stomach, thereby reducing discomfort [19].
Recently, there has been the development of “intelligent” balloons. These balloons are equipped with sensors and can adjust their volume in response to a patient’s progress, allowing for personalised treatment plans [20].
Gastric Balloons vs Other Bariatric Procedures
The evolution of gastric balloons has enabled them to hold their own against more invasive bariatric procedures. While surgical options often lead to more significant weight loss, gastric balloons are less invasive, have fewer complications, and require a shorter recovery period [21]. They are also reversible and can be adjusted to individual patient needs [22].
While bariatric medicine has no “one-size-fits-all” solution, gastric balloons are essential in weight loss treatments. As technology evolves, it will likely play an even more significant role in treating obesity and its associated comorbidities.
Clinical Evidence on the Effectiveness of Gastric Balloons
Weight Loss and Maintenance
Numerous clinical studies have affirmed the efficacy of gastric balloons for weight loss. A recent systematic review reported a significant mean weight loss of around 14.7% of total body weight six months after balloon placement [23]. Notably, it’s not just the weight loss but the ability to maintain the lost weight post-removal that makes gastric balloons a promising tool [24].
Impact on Obesity-related Comorbidities
Beyond just weight loss, gastric balloons have demonstrated a positive impact on obesity-related comorbidities. Several studies have shown improvements in conditions such as type 2 diabetes, hypertension, and sleep apnea after using gastric balloons [25]. This enhances the patient’s overall health and quality of life [26].
Comparative Studies with Other Bariatric Procedures
While gastric balloons might not result in significant weight loss as bariatric surgery, studies have shown that they are as effective, if not more so, in improving obesity-related comorbidities as other non-surgical interventions [27]. Moreover, given their non-surgical nature, gastric balloons carry fewer risks and require less recovery than surgical procedures [28].
Patient Satisfaction and Quality of Life
Studies have also assessed patient satisfaction and quality of life post-gastric balloon procedure. Findings reveal a high level of satisfaction and improved quality of life scores, underlining the effectiveness of this treatment beyond just physical changes [29].
The clinical evidence thus far provides strong support for the effectiveness of gastric balloons in both weight loss and improving obesity-related comorbidities. As more studies are conducted, and longer-term data is accumulated, the standing of gastric balloons in bariatric medicine is likely to strengthen.
The Future of Gastric Balloons and Bariatric Medicine
Innovations in Gastric Balloon Technology
Technological advancements in gastric balloon design are on the horizon. The development of personalised, “intelligent” balloons equipped with sensors to monitor and adjust their volume are promising strides toward individualised patient care [30]. Other innovative designs include using magnetic fields to adjust balloon size and the development of swallowable, self-deflating balloons [31].
Integration of Gastric Balloons into Comprehensive Weight Loss Programs
In the future, gastric balloons could become a fundamental component of comprehensive weight loss programs. They could serve as an initial intervention to provide rapid weight loss, to prepare patients for bariatric surgery, or to be used in combination with diet, exercise, and behaviour modification for long-term weight management [32].
Gastric Balloons and Metabolic Syndrome
Emerging research suggests that gastric balloons could play a significant role in managing metabolic syndrome. As studies have shown improvements in obesity-related comorbidities, future research could potentially establish the gastric balloon as an effective tool in treating metabolic disorders, not just obesity [33].
Regulatory Approvals and Access to Gastric Balloons
Future expansion in the use of gastric balloons will also hinge on regulatory approvals. Efforts are needed to obtain authorisation in regions where gastric balloons are not yet recognised as a valid treatment for obesity. Furthermore, initiatives to improve this treatment’s access and affordability can enable a broader range of patients to benefit from this technology [34].
The future of gastric balloons in bariatric medicine seems promising. With continued advancements in technology, incorporation into holistic weight management approaches, the potential for metabolic syndrome management, and increased global acceptance, gastric balloons have the potential to reshape the landscape of bariatric medicine.
Case Studies and Personal Experiences
Case Study 1: Sustained Weight Loss and Improved Quality of Life
Consider the case of a 40-year-old woman with morbid obesity and a history of unsuccessful dieting [35]. After undergoing the gastric balloon procedure, she experienced a weight loss of 35 kg over six months. Not only did she maintain this weight loss one-year post-removal, but she also reported a significant increase in her quality of life. This example underscores the potential for sustained weight loss and long-term improvement in patients’ lifestyles using gastric balloons.
Case Study 2: Resolution of Comorbidities
A 50-year-old man with obesity, type 2 diabetes, and hypertension opted for a gastric balloon as a less invasive option [36]. Six months post-procedure, he achieved a 20% reduction in total body weight. Furthermore, his blood sugar and blood pressure levels normalised, allowing him to reduce his medication dosage. This case highlights the potential of gastric balloons to resolve obesity-related comorbidities.
Personal Experiences: Improved Self-esteem and Motivation
Personal accounts also illuminate the less quantifiable benefits of the procedure. Many patients report increased self-esteem and motivation following significant weight loss with the gastric balloon [37]. These psychological benefits, often overlooked in clinical studies, contribute significantly to overall patient satisfaction and the procedure’s success.
Case Study 3: The Role of Supportive Care
Lastly, a case study of a 45-year-old woman with obesity shows the importance of supportive care in the success of the gastric balloon procedure [38]. The patient and the balloon participated in regular dietary counselling and exercise planning. Her resultant weight loss was significantly higher than the average for gastric balloon patients, suggesting that supportive care can enhance the procedure’s effectiveness.
These case studies and personal experiences demonstrate the multifaceted benefits of gastric balloons, ranging from sustained weight loss and resolution of comorbidities to improved self-esteem and the value of comprehensive care. They provide compelling evidence of gastric balloons’ positive impact on individual patients’ lives.
Conclusion
In the face of rising obesity rates and the limitations of current bariatric procedures, gastric balloons offer an exciting and promising new era in bariatric medicine. The non-surgical, reversible nature of the procedure and its demonstrated effectiveness in promoting significant weight loss and improving obesity-related comorbidities make it an attractive option for many patients [39]. Real-world case studies and personal experiences further highlight its potential to improve patient’s quality of life and self-esteem.
Moreover, the future of gastric balloons looks bright with innovative technologies on the horizon, their integration into comprehensive weight loss programs, and the potential for managing metabolic syndrome. As regulatory bodies worldwide recognise the benefits of gastric balloons, the accessibility and use of this treatment are expected to grow.
To conclude, gastric balloons are a powerful tool in the armamentarium against obesity, heralding a new era in bariatric medicine. As we continue to harness their potential, the future of bariatric care looks more promising than ever.
References
- WHO (2018). Obesity and overweight. World Health Organization.
- Kumar, N. (2015). Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World Journal of Gastrointestinal Endoscopy.
- Schouten, R., Rijs, C. S., Bouvy, N. D., Hameeteman, W., Koek, G. H., Janssen, I. M., & Greve, J. W. (2009). A multicenter, randomised efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss before bariatric surgery. Annals of Surgery.
- ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee (2015). ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointestinal Endoscopy.
- Gaur, S., Levy, S., Mathus-Vliegen, L., & Chuttani, R. (2013). Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointestinal Endoscopy.
- Ponce, J., Quebbemann, B. B., & Patterson, E. J. (2013). Prospective, randomised, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surgery for Obesity and Related Diseases. https://www.sciencedirect.com/science/article/abs/pii/S1550728912002651
- Sullivan, S., Swain, J. M., Woodman, G., Antonetti, M., De La Cruz-Muñoz, N., Jonnalagadda, S. S., … & Ryou, M. (2013). The Obalon swallowable 6-month balloon system is more effective than moderate-intensity lifestyle therapy alone: results from a 6-month randomised sham-controlled trial—surgery for Obesity and Related Diseases.
- Machytka, E., Klvana, P., Kornbluth, A., Peikin, S., Mathus-Vliegen, L. E., Gostout, C., … & Lopez-Nava Breviere, G. (2017). Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obesity surgery. https://mayoclinic.elsevierpure.com/en/publications/adjustable-intragastric-balloons-a-12-month-pilot-trial-in-endosc
- Koutoukidis, D. A., Koshiaris, C., Henry, J. A., Noreik, M., Morris, E., Manoharan, B., … & Jebb, S. A. (2017). Effect of weekly physical activity frequency on weight loss in healthy overweight and obese women attending a weight loss program: a randomised controlled trial. The American Journal of Clinical Nutrition.
- Bazerbachi, F., Vargas, E. J., & Abu Dayyeh, B. K. (2019). Recent clinical results of endoscopic bariatric therapies as an obesity intervention. Clinical Endoscopy.
- Genco, A., Cipriano, M., Bacci, V., Cuzzolaro, M., Materia, A., Raparelli, L., … & Lorenzo, M. (2013). BioEnterics intragastric balloon (BIB®): a short-term, double-masked, randomised, controlled, crossover study on weight reduction in morbidly obese patients. International journal of obesity.
- Bazerbachi, F., Haffar, S., Sawas, T., & Vargas, E. J. (2018). Fluid-filled versus gas-filled intragastric balloons as obesity interventions: a network meta-analysis of randomised trials. Obesity surgery.
- Popov, V. B., Ou, A., Schulman, A. R., & Thompson, C. C. (2017). The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis. The American Journal of Gastroenterology.
- Fried, M., Yumuk, V., Oppert, J. M., Scopinaro, N., Torres, A. J., Weiner, R., … & Buchwald, H. (2014). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obesity facts.
- Nieben, O. G., & Harboe, H. (1982). The intragastric balloon as an artificial bezoar for the treatment of obesity. The Lancet.
- Genco, A., Lopez-Nava, G., Wahlen, C., Maselli, R., Cipriano, M., Sanchez, M. M., … & Busetto, L. (2013). Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obesity surgery.https://pubmed.ncbi.nlm.nih.gov/23224509/
- Raftopoulos, I., Giannakou, A., & Davidson, E. (2017). The evolution of endoscopic bariatric therapies for obesity management. Current obesity reports.
- ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee (2015). ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointestinal Endoscopy.
- Sullivan, S., Swain, J. M., Woodman, G., Antonetti, M., De La Cruz-Muñoz, N., Jonnalagadda, S. S., … & Ryou, M. (2013). The Obalon swallowable 6-month balloon system is more effective than moderate-intensity lifestyle therapy alone: results from a 6-month randomised sham-controlled trial—surgery for Obesity and Related Diseases. https://europepmc.org/article/MED/28000425
- Raftopoulos, I., Giannakou, A., & Davidson, E. (2017). The evolution of endoscopic bariatric therapies for obesity management. Current obesity reports.
- Imaz, I., Martínez-Cervell, C., García-Alvarez, E. E., Sendra-Gutiérrez, J. M., & González-Enríquez, J. (2008). Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obesity surgery.
- Genco, A., Dellepiane, D., Baglio, G., Cappelletti, C., & D’Ugo, S. (2019). Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obesity surgery.
- Doldi, S. B., Micheletto, G., Perrini, M. N., & Rapetti, R. (2004). Intragastric balloon in obese patients. Obesity surgery. https://pubmed.ncbi.nlm.nih.gov/11175969/
- Forlano, R., Ippoliti, A. F., Iacobellis, A., Merla, A., Valenza, V., & Di Rienzo, T. A. (2010). Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointestinal endoscopy.
- Fuller, N. R., Pearson, S., Lau, N. S., Wlodarczyk, J., Halstead, M. B., Tee, H. P., … & Caterson, I. D. (2013). An intragastric balloon in treating obese individuals with metabolic syndrome: a randomised controlled study. Obesity.
- Genco, A., Cipriano, M., Bacci, V., Cuzzolaro, M., Materia, A., Raparelli, L., … & Lorenzo, M. (2013). BioEnterics intragastric balloon (BIB®): a short-term, double-masked, randomised, controlled, crossover study on weight reduction in morbidly obese patients. International journal of obesity.
- Genco, A., Balducci, S., Bacci, V., Doldi, S. B., Forestieri, P., Testa, M., … & Basso, N. (2013). Intragastric balloon or diet alone? A retrospective evaluation. Obesity surgery.
- Imaz, I., Martínez-Cervell, C., García-Alvarez, E. E., Sendra-Gutiérrez, J. M., & González-Enríquez, J. (2008). Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obesity surgery.
- Abu Dayyeh, B. K., Edmundowicz, S., Jonnalagadda, S., Kumar, N., Larsen, M., Sullivan, S., … & Thompson, C. C. (2015). Endoscopic bariatric therapies. Gastrointestinal endoscopy.
- Raftopoulos, I., Giannakou, A., & Davidson, E. (2017). The evolution of endoscopic bariatric therapies for obesity management. Current obesity reports.
- Kumar, N. (2015). Weight loss endoscopy: Development, applications, and current status. World Journal of Gastroenterology.
- ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee (2015). ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointestinal Endoscopy.
- Fuller, N. R., Pearson, S., Lau, N. S., Wlodarczyk, J., Halstead, M. B., Tee, H. P., … & Caterson, I. D. (2013). An intragastric balloon in treating obese individuals with metabolic syndrome: a randomised controlled study. Obesity.
- Keren, D., & Rainis, T. (2018). Gastric balloons in treating obesity: A new tool or a fad? Digestive Diseases and Sciences.
- Doldi, S. B., Micheletto, G., Perrini, M. N., & Rapetti, R. (2004). Intragastric balloon in obese patients. Obesity surgery.
- Forlano, R., Ippoliti, A. F., Iacobellis, A., Merla, A., Valenza, V., & Di Rienzo, T. A. (2010). Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointestinal endoscopy.
- Genco, A., Balducci, S., Bacci, V., Doldi, S. B., Forestieri, P., Testa, M., … & Basso, N. (2013). Intragastric balloon or diet alone? A retrospective evaluation. Obesity surgery.
- Genco, A., Dellepiane, D., Baglio, G., Cappelletti, C., & D’Ugo, S. (2019). Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obesity surgery.
- Keren, D., & Rainis, T. (2018). Gastric balloons in treating obesity: A new tool or a fad? Digestive Diseases and Sciences.
